(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of UGT2B1 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in decreased expression of UGT2B17 mRNA CTD PMID:27840820 1-naphthaleneacetic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthaleneacetic acid CTD PMID:8302279 1-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthol CTD PMID:8302279 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of UGT2B1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of UGT2B1 protein CTD PMID:12663690 17alpha-ethynylestradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ethinyl Estradiol CTD PMID:15921999 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of UGT2B1 protein CTD PMID:12663690 17alpha-ethynylestradiol multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein] and Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 17beta-estradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Estradiol CTD PMID:11836149 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of UGT2B17 mRNA and Estradiol results in increased expression of UGT2B17 protein CTD PMID:32145629 17beta-estradiol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Estradiol results in increased expression of UGT2B17 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Dihydrotestosterone CTD PMID:8798464 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:10036216 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31826744 and PMID:32679240 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UGT2B4 mRNA CTD PMID:20558275 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 and PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:21215274 and PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGT2B1 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of UGT2B1 mRNA CTD PMID:21346803 2-Ethylhexanoic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylhexanoic acid CTD PMID:8302279 2-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylphenol CTD PMID:8302279 2-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-naphthol CTD PMID:8302279 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of UGT2B17 mRNA CTD PMID:23052194 3-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-ethylphenol CTD PMID:8302279 3-phenylpropionic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-phenylpropionic acid CTD PMID:8302279 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 more ... CTD PMID:19162173 and PMID:19695238 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 4-ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-ethylphenol CTD PMID:8302279 4-hydroxyphenyl retinamide increases expression ISO Ugt2b1 (Mus musculus) 6480464 Fenretinide results in increased expression of UGT2B17 mRNA CTD PMID:28973697 4-methylumbelliferone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Hymecromone CTD PMID:8302279 4-methylumbelliferone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Hymecromone CTD PMID:8798464 4-methylumbelliferone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide and licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 and PMID:33290829 4-methylumbelliferone increases activity ISO UGT2B17 (Homo sapiens) 6480464 Hymecromone results in increased activity of UGT2B17 protein CTD PMID:26875642 4-methylumbelliferone increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Hymecromone CTD PMID:33290829 4-methylumbelliferone beta-D-glucuronide multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide CTD PMID:33290829 4-tert-butylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of butylphen CTD PMID:8302279 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of UGT2B1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of UGT2B1 mRNA CTD PMID:25825206 8-Br-cAMP increases expression ISO UGT2B17 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA CTD PMID:22079614 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGT2B1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:23052194 and PMID:33354967 aflatoxin B1 increases expression ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:21641981 aflatoxin B1 decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of UGT2B17 gene CTD PMID:27153756 aldrin increases expression ISO Ugt2b1 (Mus musculus) 6480464 Aldrin results in increased expression of UGT2B1 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tretinoin results in decreased expression of UGT2B17 mRNA CTD PMID:23724009 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UGT2B1 mRNA CTD PMID:16940010 and PMID:17785943 amentoflavone decreases activity ISO UGT2B17 (Homo sapiens) 6480464 amentoflavone results in decreased activity of UGT2B17 protein CTD PMID:29470958 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of UGT2B1 mRNA CTD PMID:18355885 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of UGT2B1 mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UGT2B1 mRNA CTD PMID:16483693 androstane-3,17-diol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androstane-3 and 17-diol CTD PMID:8798464 androsterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androsterone CTD PMID:8798464 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of UGT2B17 mRNA CTD PMID:23912714 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of UGT2B1 mRNA CTD PMID:18178546 Aroclor 1254 affects expression ISO UGT2B17 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) affects the expression of UGT2B17 mRNA CTD PMID:17851650 atrazine affects expression EXP 6480464 Atrazine affects the expression of UGT2B17 mRNA CTD PMID:22285353 benzene affects expression EXP 6480464 Benzene affects the expression of UGT2B1 mRNA CTD PMID:15878777 benzo[a]pyrene increases expression ISO Ugt2b1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of UGT2B1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 benzyl alcohol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Benzyl Alcohol CTD PMID:8302279 bezafibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Bezafibrate CTD PMID:8302279 bicalutamide decreases expression ISO UGT2B17 (Homo sapiens) 6480464 bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 biphenyl-4-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-phenylphenol CTD PMID:11836149 more ... bis(2-ethylhexyl) phthalate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA] CTD PMID:19850644 bisphenol A increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of bisphenol A CTD PMID:10333482 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGT2B1 mRNA and bisphenol A results in increased expression of UGT2B17 protein CTD PMID:29960846 and PMID:32145629 bisphenol A increases expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol A results in increased expression of UGT2B1 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGT2B1 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGT2B1 mRNA more ... CTD PMID:12230427 and PMID:25181051 buta-1,3-diene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of UGT2B1 mRNA CTD PMID:29038090 butylated hydroxyanisole decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Butylated Hydroxyanisole results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 calcitriol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Calcitriol results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 captan increases expression ISO Ugt2b1 (Mus musculus) 6480464 Captan results in increased expression of UGT2B15 mRNA CTD PMID:31558096 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of UGT2B1 mRNA CTD PMID:17381134 carbon nanotube decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chloramphenicol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Chloramphenicol CTD PMID:8302279 chlorogenic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Chlorogenic Acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 ciprofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of ciprofibrate CTD PMID:8302279 cis-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of UGT2B17 protein CTD PMID:22023808 clofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibrate CTD PMID:8302279 clofibrate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 clofibrate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [Clofibrate co-treated with PPARA protein mutant form] results in increased expression of UGT2B1 mRNA CTD PMID:22496397 clofibric acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibric Acid CTD PMID:8302279 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA CTD PMID:17602206 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of UGT2B1 mRNA CTD PMID:10476907 cyclosporin A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGT2B1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of UGT2B17 mRNA CTD PMID:27989131 cylindrospermopsin decreases expression ISO UGT2B17 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of UGT2B17 mRNA CTD PMID:30905859 cylindrospermopsin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of UGT2B1 mRNA CTD PMID:20936652 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 daidzein increases expression ISO UGT2B17 (Homo sapiens) 6480464 daidzein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 DDE multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of UGT2B1 mRNA CTD PMID:32679240 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UGT2B1 mRNA and Dexamethasone results in increased expression of UGT2B17 mRNA CTD PMID:11328961 more ... dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of UGT2B1 mRNA CTD PMID:15102944 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of UGT2B4 mRNA CTD PMID:19695238 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UGT2B1 mRNA CTD PMID:15901914 dichloroacetic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of UGT2B1 mRNA CTD PMID:28962523 diclofenac increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Diclofenac CTD PMID:15843492 and PMID:22265884 diethylstilbestrol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Diethylstilbestrol CTD PMID:11836149 diethylstilbestrol increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of UGT2B1 mRNA CTD PMID:20163289 diquat decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diquat results in decreased expression of UGT2B17 protein CTD PMID:36851058 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UGT2B1 mRNA CTD PMID:26335259 doxorubicin multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] CTD PMID:26335259 elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 endosulfan multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UGT2B1 mRNA CTD PMID:29391264 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of UGT2B17 mRNA CTD PMID:29391264 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 equol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Equol results in increased expression of UGT2B17 mRNA CTD PMID:16865672 ethyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 eugenol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Eugenol CTD PMID:8798464 felbamate increases expression EXP 6480464 felbamate results in increased expression of UGT2B1 mRNA CTD PMID:17381134 fipronil increases expression ISO Ugt2b1 (Mus musculus) 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of UGT2B1 mRNA CTD PMID:16643972 flumequine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 flumequine results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 flumequine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 flurbiprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Flurbiprofen CTD PMID:8302279 flutamide increases expression EXP 6480464 Flutamide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 folpet increases expression ISO Ugt2b1 (Mus musculus) 6480464 folpet results in increased expression of UGT2B15 mRNA CTD PMID:31558096 formaldehyde increases expression ISO UGT2B17 (Homo sapiens) 6480464 Formaldehyde results in increased expression of UGT2B17 mRNA CTD PMID:23649840 fumonisin B1 multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA and [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA CTD PMID:30448865 gabapentin increases expression EXP 6480464 gabapentin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 genistein multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:23333575 genistein increases expression ISO UGT2B17 (Homo sapiens) 6480464 Genistein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of UGT2B1 mRNA and Glutathione deficiency results in increased expression of UGT2B4 mRNA CTD PMID:15345336 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of UGT2B1 mRNA CTD PMID:15159207 hydratropic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of hydratropic acid CTD PMID:8302279 ibuprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ibuprofen CTD PMID:8302279 imipramine affects expression EXP 6480464 Imipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of UGT2B1 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B17 mRNA CTD PMID:22129741 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of UGT2B1 mRNA CTD PMID:18355885 ketoprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ketoprofen CTD PMID:8302279 L-ascorbic acid multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Lasiocarpine increases expression EXP 6480464 lasiocarpine results in increased expression of UGT2B17 mRNA CTD PMID:32419051 Licochalcone A multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 lipopolysaccharide decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of UGT2B17 mRNA CTD PMID:21311750 lorcaserin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased carbamoylation of and results in increased glucuronidation of lorcaserin CTD PMID:22259019 MeIQx multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 methyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of UGT2B1 mRNA CTD PMID:10036216 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of UGT2B1 mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of UGT2B1 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UGT2B1 mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of UGT2B1 mRNA CTD PMID:17942915 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of UGT2B1 mRNA CTD PMID:22037397 naproxen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Naproxen CTD PMID:8302279 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UGT2B17 mRNA CTD PMID:24136188 nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of UGT2B1 mRNA CTD PMID:16408618 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Nonylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of nonylphenol CTD PMID:11836149 O-methyleugenol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 methyleugenol results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 oltipraz decreases expression ISO Ugt2b1 (Mus musculus) 6480464 oltipraz results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 oltipraz multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of UGT2B1 mRNA CTD PMID:23665939 p-cresol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-cresol CTD PMID:8302279 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of UGT2B1 mRNA CTD PMID:27638505 pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UGT2B1 mRNA CTD PMID:30723492 paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 paracetamol multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:23333575 more ... paracetamol decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:23333575 more ... paracetamol affects expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen affects the expression of UGT2B1 mRNA CTD PMID:17562736 pectolinarigenin increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of pectolinarigenin CTD PMID:37797876 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of UGT2B1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of UGT2B1 mRNA and perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA CTD PMID:17681415 and PMID:18467677 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of UGT2B17 mRNA CTD PMID:28511854 perfluorooctanoic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 perfluorooctanoic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 phenformin increases expression EXP 6480464 Phenformin results in increased expression of UGT2B1 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA more ... CTD PMID:10036216 more ... phenobarbital increases expression ISO Ugt2b1 (Mus musculus) 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA CTD PMID:19760798 phenobarbital decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Phenobarbital results in decreased expression of UGT2B17 mRNA CTD PMID:19084549 phenobarbital multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of UGT2B17 protein CTD PMID:8263600 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 phloretin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phloretin results in decreased activity of UGT2B17 protein CTD PMID:35868516 phlorizin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phlorhizin results in decreased activity of UGT2B17 protein CTD PMID:35868516 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of UGT2B1 mRNA and Piperonyl Butoxide results in increased expression of UGT2B17 mRNA CTD PMID:17498859 more ... piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of UGT2B17 mRNA and Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of UGT2B17 mRNA] CTD PMID:18544911 and PMID:18648771 pirinixic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 pirinixic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA and pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:18467677 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA and pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:19162173 and PMID:22484513 pirprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of pirprofen CTD PMID:8302279 poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of UGT2B1 mRNA CTD PMID:23939143 pravastatin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of UGT2B1 mRNA CTD PMID:19162173 and PMID:22037397 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of UGT2B1 mRNA CTD PMID:29038839 propiconazole increases expression ISO Ugt2b1 (Mus musculus) 6480464 propiconazole results in increased expression of UGT2B1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of UGT2B1 mRNA and propiconazole results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... quercetin 3-O-beta-D-galactopyranoside multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:26772156 quercetin 3-O-beta-D-galactopyranoside increases expression ISO Ugt2b1 (Mus musculus) 6480464 hyperoside results in increased expression of UGT2B1 mRNA CTD PMID:26772156 quinolines increases expression EXP 6480464 Quinolines results in increased expression of UGT2B1 mRNA CTD PMID:9176741 rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 rotenone increases expression EXP 6480464 Rotenone results in increased expression of UGT2B1 mRNA CTD PMID:28374803 selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 senecionine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 senecionine results in decreased expression of UGT2B1 mRNA CTD PMID:31606820 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of UGT2B1 mRNA CTD PMID:8706011 taurine multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:26335259 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of UGT2B1 protein CTD PMID:24090815 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of UGT2B1 mRNA CTD PMID:21515302 testosterone increases expression ISO Ugt2b1 (Mus musculus) 6480464 Testosterone results in increased expression of UGT2B1 mRNA CTD PMID:20844152 testosterone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 testosterone decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 testosterone increases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in increased expression of UGT2B17 mRNA CTD PMID:21880219 testosterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Testosterone CTD PMID:8798464 testosterone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Testosterone CTD PMID:11836149 and PMID:8302279 Testosterone propionate decreases expression EXP 6480464 Testosterone Propionate results in decreased expression of UGT2B1 mRNA CTD PMID:16829708 tetrachloromethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 more ... tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UGT2B1 mRNA CTD PMID:32380060 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA and Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of UGT2B17 mRNA and Thioacetamide results in increased expression of UGT2B4 mRNA CTD PMID:37008694 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGT2B17 mRNA CTD PMID:34492290 trans-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of UGT2B1 mRNA and triadimefon results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... trichloroethene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of UGT2B1 mRNA CTD PMID:25549359 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of UGT2B17 mRNA CTD PMID:33387578 trifluralin increases expression EXP 6480464 Trifluralin results in increased expression of UGT2B1 mRNA CTD PMID:18582544 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of UGT2B1 mRNA CTD PMID:30589522 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 uranium atom multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein] and Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 ursodeoxycholic acid increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Ursodeoxycholic Acid CTD PMID:31299240 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of UGT2B17 mRNA CTD PMID:24136188 valproic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGT2B17 mRNA CTD PMID:29154799 valproic acid decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of UGT2B17 gene CTD PMID:29154799 valproic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Valproic Acid CTD PMID:8302279 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UGT2B1 mRNA CTD PMID:17381134 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGT2B17 mRNA CTD PMID:22285353 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of UGT2B4 mRNA CTD PMID:28923436 vorinostat increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of vorinostat CTD PMID:25393417 vorinostat multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat and Warfarin inhibits the reaction [UGT2B17 protein results in increased glucuronidation of vorinostat] CTD PMID:25393417 warfarin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat more ... CTD PMID:25393417 zaragozic acid A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 squalestatin 1 results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of UGT2B1 mRNA CTD PMID:27225895 zidovudine increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Zidovudine CTD PMID:8302279 zinc acetate multiple interactions EXP 6480464 [Taurine co-treated with Zinc Acetate] results in increased expression of UGT2B1 mRNA CTD PMID:26335259 zinc atom multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] and [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259 zinc(0) multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] and [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259